clovis oncology inc
(CLVS:Consolidated Issue Listed on NASDAQ Global Select )
Thorlef Spickschen Ph.D.
Director and Member of Compensation Committee, Clovis Oncology, Inc.
|Age||Total Calculated Compensation||This person is connected to 10 board members in 2 different organizations across 8 different industries.|
See Board Relationships
Dr. Thorlef Spickschen is the Chairman of Investors Committee at Heidelberg Innovation Gruppe, Heidelberg Innovation BioScience Venture II GmbH & Co. KG, L.P., and the Vice Chairman of BioVisioN AG. Dr. Spickschen has been a Director of Weston Medical Group PLC since January 2002 and December 2001. In addition to Weston Medical, he also serves on the Board of several academic and social institutions. Dr. Spickschen has been a Director of Pharmion Corp. since December ...
2525 28th StreetPhone: 303-625-5000
Boulder, Colorado 80301
Board Members Memberships*
Independent Director, Member of Audit Committee and Member of Compensation Committee
Former Director, Member of Compensation Committee and Member of Corporate Governance & Nominating Committee
Former Vice Chairman
Director and Member of Compensation Committee
Education*There is no Education data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|There is no Competitor Compensation data available.|